Minimum Investment
Minimum Investment (Retail) | Lots (min) | Shares (QTY) |
₹1,33,200 | 1 | 1200 |
About Amwill Healthcare Limited IPO
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies. This collaboration has enhanced the company’s manufacturing, packaging, and distribution capabilities.
The product portfolio of the Company is divided into two categories, namely,
- Development of generic dermatological solutions and
- Formulating targeted solutions for dermatological issues.
The company markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before entering new markets to build a customer base.
The company develops products for dermatological disorders, including acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo.
As of September 30, 2024, the company has 84 employees on payroll.
read more >
Competitive Strengths:
- Extensive product portfolio supported by product formulation capabilities
- Provision of high-quality product development through tie-ups with contract manufacturers and prototype developers
- Well-experienced management team with proven project management and implementation skills
- Asset-light business model.
Amwill Healthcare Limited IPO Details
IPO Date | February 5, 2025 to February 7, 2025 |
Face Value | ₹10 per share |
Price Band | ₹105 to ₹111 per share |
Lot Size | 1,200 Shares |
Total Issue Size | 54,03,600 shares (aggregating up to ₹59.98 Cr) |
Fresh Issue | 44,03,600 shares (aggregating up to ₹ 48.88 Cr) |
Offer for Sale | 10,00,000 shares of ₹10 (aggregating up to ₹11.10 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE SME |
Share Holding Pre Issue | 1,56,00,000 shares |
Share Holding Post Issue | 2,00,03,600 shares |
IPO Open Date | Wednesday, February 5, 2025 |
IPO Close Date | Friday, February 7, 2025 |
Basis of Allotment | Monday, February 10, 2025 |
Initiation of Refunds | Tuesday, February 11, 2025 |
Credit of Shares to Demat | Tuesday, February 11, 2025 |
Listing Date | Wednesday, February 12, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on February 7, 2025 |
Amwill Healthcare Limited IPO Prospectus
Amwill Healthcare Limited Financial Snapshot (in Crore)
Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | 28.89 | 18.98 | 12.39 | 6.59 |
Revenue | 23.25 | 44.28 | 30.28 | 27.62 |
Profit After Tax | 6.52 | 12.54 | 3.11 | 2.57 |
Net Worth | 23.68 | 17.16 | 4.6 | 1.49 |
Reserves and Surplus | 8.08 | 17.11 | 4.57 | 1.46 |
Amwill Healthcare Limited Promoters Holding
Anand Gandhi and Tarun Gandhi
Amwill Healthcare Limited IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Amwill Healthcare Limited IPO Lead Manager(s)
Unistone Capital Pvt Ltd
Amwill Healthcare Limited Contact Details
Amwill Healthcare Limited
No. 157, 1st Floor,
2nd Main, r, 2nd Main, 3rd Cross Chamrajpet
Bangalore – 560018
Phone: +91 8043026281
Email: amwill@amwillhealthcare.com
Website: https://www.amwillhealthcare.com/